Canonical Smad3 signaling and ERK/Sp1 signaling pathways were also crucial for the TGF‐β‐induced upregulation of EGFR expression and the enhancement of migration and invasion abilities of breast cancer cells. Here, EGFR is linked to breast carcinoma.